• Angiotensin Peptides Enhance Spike–Receptor Binding

  2026-09-25

  A 2025 study reports that several naturally occurring angiotensin peptides increase SARS-CoV-2 spike protein binding to host receptors in antibody-based assays, with peptide sequence and receptor type shaping the effect. The results connect renin-angiotensin system biology with a possible viral-entry mechanism, but do not establish enhanced infection or clinical consequences.

• Exemestane in Breast Cancer Research Workflows

  2026-09-25

  Use Exemestane to test estrogen production at its source, with workflows suited to aromatase-containing microsomes and hormone-responsive cell models. Its irreversible enzyme inactivation makes time course, washout, and vehicle controls especially important when interpreting results alongside clinical endocrine-therapy evidence.

• Etomoxir as a Causal Probe in Immunometabolism

  2026-09-24

  Etomoxir can help test how fatty acid oxidation shapes immune function, but a change in cytokines is not, by itself, proof of target-specific metabolic control. This guide connects standardized whole-blood stimulation with concentration-aware design, orthogonal readouts, and cautious interpretation across cell and disease models.

• hiPSC Differentiation into Corneal Endothelial-Like Cells

  2026-09-24

  This study reports a two-stage, serum-free method for directing human induced pluripotent stem cells through a neural crest intermediate toward corneal endothelial-like cells. Its practical contribution is a defined sequence of signaling cues and marker-based checks, while the results support cell identity more strongly than mature endothelial function.

• Amiloride (MK-870): Research Uses and Limits

  2026-09-23

  Amiloride (MK-870) is a research inhibitor used to investigate epithelial sodium channel activity, ion transport, and uPAR-associated processes. It is not the agent studied in the cited nanovaccine research, so any connection to cellular endocytosis modulation or vaccine design should be treated as a separate experimental question.

• PF-562271 HCl: Designing Immune-Ready FAK Assays

  2026-09-23

  PF-562271 HCl is a selective FAK/Pyk2 inhibitor for investigating adhesion signaling, tumor growth inhibition, and immune remodeling. This guide translates recent radiotherapy-immunotherapy findings into assay strategies that connect FAK phosphorylation inhibition with abscopal effects and CD8+ T-cell memory.

• Foretinib–Anti-CD47 Immunotherapy in CRC

  2026-09-22

  The reference study identifies foretinib as an inducer of immunogenic cell death in colorectal cancer through a p53–DR5 apoptotic pathway and coordinated release of calreticulin, ATP, and HMGB1. Its combination with anti-CD47 immunotherapy links direct tumor-cell killing to dendritic-cell and T-cell activation, providing a rationale for ATP-centered immune monitoring.

• Cellular Senescence Signatures in AAA Diagnosis

  2026-09-22

  The reference study integrates transcriptomics, senescence biology, machine learning, and experimental validation to identify ETS1 and ITPR3 as candidate biomarkers for abdominal aortic aneurysm. Its workflow provides a useful framework for moving from broad gene screening to stage-aware biomarker evaluation, while also highlighting senescent endothelial cells as a potentially important cellular compartment.

• Pyruvate Carboxylase, Ferroptosis, and NSCLC

  2026-09-21

  A 2026 Cancer Letters study identifies pyruvate carboxylase as an ATP-linked regulator of ferroptosis resistance and non-small cell lung cancer progression. Its findings connect PC–AMPK–AKT/mTOR signaling with fatty-acid synthesis and suggest that manipulating PC regulation may improve ferroptosis- and immunotherapy-based strategies.

• Tomivosertib: From MNK Target to Human Neurons

  2026-09-21

  Tomivosertib is a potent MNK1 inhibitor that links rapid eIF4E Ser209 dephosphorylation to altered excitability in human dorsal root ganglion neurons. This article translates the key human-neuron findings into practical assay-design decisions while defining the limits of extrapolating neuronal data to cancer and metabolic models.

• RIG-I, c-Myc, and Renal Fibrosis in UUO Mice

  2026-09-20

  A 2020 Journal of Molecular Medicine study identifies RIG-I as an injury-induced amplifier of renal tubulointerstitial fibrosis. Its experiments connect tubular NF-κB-dependent cytokine release with c-Myc-driven TGF-β/Smad signaling and fibroblast activation, providing a mechanistic framework for studying inflammatory drivers of chronic kidney disease.

• 1-Phenyl-2-Pentanol in Liver Fibrosis

  2026-09-19

  The reference study identifies 1-phenyl-2-pentanol from Moringa oleifera leaves as an inhibitor of TGF-β1-stimulated hepatic stellate cell activation. By combining fibrosis-marker analysis with proteomics and molecular docking, it links the compound’s activity to TGF-β1 and Wnt/β-catenin pathway modulation while highlighting the need for validation beyond an in vitro model.

• Prestained Protein Marker: Practical SDS-PAGE Guide

  2026-09-18

  This guide explains how F4005 supports molecular-weight estimation during SDS-PAGE, transfer checks in Western blotting, and fluorescence-oriented membrane imaging. It should be used as a visible migration and transfer reference, not as a substitute for a target-specific loading control, antibody control, or quantitative protein standard.

• Ethacridine Lactate Monohydrate in SE Assays

  2026-09-18

  Ethacridine lactate monohydrate can strengthen contamination-aware assay design without being mistaken for a differentiation reagent. This guide connects its handling and antiseptic role with YAP–TEAD super-enhancer research and shows how to separate microbial growth inhibition from genuine surface ectoderm biology.

• Cy3-dCTP: Designing Better Fluorescent Assays

  2026-09-17

  Cy3-dCTP enables direct fluorescent labeling of DNA and cDNA, but assay quality depends on controlling substrate accessibility, incorporation density, and signal interpretation. This guide connects Cyanine 3-deoxycytidine triphosphate workflows with DNA-interface engineering to improve experimental decisions.

7948 records 1/530 page Next 12345 下5页 Last page